ABUJA, NIGERIA — The World Health Organization (WHO) has confirmed that the Ebola virus species detected in Nigeria has no approved vaccine or specific treatment, raising concerns as health authorities intensify efforts to prevent the deadly disease from spreading.
The warning follows Nigeria’s confirmation on October 20, 2026, of its first Ebola infection in more than a decade, involving the Bundibugyo virus, a rare species responsible for a rapidly expanding outbreak across parts of Africa.
According to WHO, the patient is a woman who recently travelled from Uganda to Abuja, where she developed symptoms on October 7. She sought medical attention at a private health facility on October 11, but laboratory confirmation was not obtained until October 20. The woman has since been isolated and is receiving supportive medical care. Nigeria’s Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate, acknowledged that no licensed vaccine or targeted medication currently exists for the Bundibugyo virus.
However, he explained that medical professionals were providing appropriate supportive treatment to manage the patient’s symptoms and improve her chances of recovery.
Pate disclosed that the woman was stable when he addressed the situation, although he cautioned that her condition could change. Health officials have identified 44 people who may have been exposed, including individuals linked to the patient’s healthcare and travel history. The Nigeria Centre for Disease Control and Prevention has activated its emergency response system, coordinating contact tracing, surveillance and infection prevention measures.
WHO has also intensified collaboration with Nigerian authorities, providing technical assistance, protective equipment and support for laboratory testing. The latest development comes amid a worsening outbreak in the Democratic Republic of Congo, where WHO recorded 9,704 confirmed infections and 4,687 deaths as of October 20. Kenya has also reported nine confirmed cases, including one death. Unlike the more familiar Ebola virus species for which approved vaccines and treatments exist, Bundibugyo virus disease currently lacks licensed, species-specific medical countermeasures.
Nevertheless, WHO stresses that early diagnosis, isolation, fluid replacement and intensive supportive care can improve survival. The virus spreads through direct contact with infected bodily fluids or contaminated materials, rather than ordinary airborne transmission. Meanwhile, investigators are examining the Nigerian patient’s travel history to determine where she contracted the infection. WHO has urged countries to strengthen border surveillance, laboratory preparedness and public awareness while advising against unnecessary travel or trade restrictions. With Nigeria’s first imported case confirmed, health authorities face mounting pressure to prevent further transmission and maintain public confidence in the country’s emergency response.




















